Breaking News Instant updates and real-time market news.

UNP

Union Pacific

$166.25

1.21 (0.73%)

06:08
03/19/19
03/19
06:08
03/19/19
06:08

Union Pacific downgraded to Hold from Buy at Loop Capital

Loop Capital analyst Rick Paterson downgraded Union Pacific to Hold from Buy and lowered his price target for the shares to $182 from $193.

UNP Union Pacific
$166.25

1.21 (0.73%)

01/25/19
ARGS
01/25/19
NO CHANGE
Target $175
ARGS
Buy
Union Pacific price target raised to $175 from $155 at Argus
Argus analyst John Eade raised his price target on Union Pacific to $175 and kept his Buy rating, saying the stock is in "recovery mode" given the recent improvement in the energy market. The analyst also points to the "strengthening underlying demand for rail transport" and more positive overall volume trends, adding that the company's earnings are further supported by its industry-low operating ratio.
01/24/19
LOOP
01/24/19
NO CHANGE
Target $193
LOOP
Buy
Loop raises Union Pacific price target to $193, sees good fortune continuing
Following Union Pacific's Q4 earnings report, Loop Capital analyst Rick Paterson said it is "a little remarkable how Union Pacific's fortunes have inflected to the positive since October," though he sees "more to come" for the stock. Union Pacific had seemed determined to implement PSR primarily with in-house talent prior to hiring Jim Vena, and operating metrics following the October phase I implementation evidenced a strong start, but the Vena hire "was clearly a positive" and "the icing on the cake in terms of investor sentiment," Paterson added. He raised his price target on Union Pacific shares to $193 from $188 and keeps a Buy rating on the stock.
01/15/19
FBCO
01/15/19
NO CHANGE
Target $180
FBCO
Outperform
Union Pacific price target raised to $180 from $166 at Credit Suisse
Credit Suisse analyst Allison Landry raised her price target for Union Pacific to $180 from $166 due to a lower discount rate and higher EBIT growth rate in her DCF model. The analyst reiterates an Outperform rating on the shares.
01/10/19
SPHN
01/10/19
NO CHANGE
Target $170
SPHN
Overweight
Stephens reiterates Union Pacific as a best idea for 2019 after pre-announcement
After Union Pacific upwardly revised its margin expectation for 2018 following the close yesterday, Stephens analyst Justin Long called the pre-announcement "another encouraging development" after Monday's news of the hiring of PSR veteran Jim Vena as its new COO. Long reiterated the stock as his best idea for 2019 and keeps an Overweight rating and $170 price target on the shares.

TODAY'S FREE FLY STORIES

TEUM

Pareteum

$1.02

-0.105 (-9.33%)

07:23
10/17/19
10/17
07:23
10/17/19
07:23
Downgrade
Pareteum rating change  »

Pareteum downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CTLT

Catalent

$48.83

-0.39 (-0.79%)

07:22
10/17/19
10/17
07:22
10/17/19
07:22
Initiation
Catalent initiated  »

Catalent resumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 05

    Nov

CDEV

Centennial Resource Development

$3.42

0.09 (2.70%)

07:22
10/17/19
10/17
07:22
10/17/19
07:22
Hot Stocks
Centennial Resource Development appoints Steven Shapiro to board of directors »

Centennial Resource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

CAKE

Cheesecake Factory

$38.41

0.06 (0.16%)

07:21
10/17/19
10/17
07:21
10/17/19
07:21
Downgrade
Cheesecake Factory rating change  »

Cheesecake Factory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 04

    Nov

  • 12

    Nov

NFLX

Netflix

$286.83

2.59 (0.91%)

07:20
10/17/19
10/17
07:20
10/17/19
07:20
Recommendations
Netflix analyst commentary  »

Netflix guidance adds…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

AKG

Asanko Gold

$0.90

-0.0083 (-0.91%)

, GFI

Gold Fields

$5.52

0.15 (2.79%)

07:19
10/17/19
10/17
07:19
10/17/19
07:19
Hot Stocks
Asanko Gold reports Q3 AGM gold production of 62,440 ounces »

Asanko Gold (AKG)…

AKG

Asanko Gold

$0.90

-0.0083 (-0.91%)

GFI

Gold Fields

$5.52

0.15 (2.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$286.83

2.59 (0.91%)

07:17
10/17/19
10/17
07:17
10/17/19
07:17
Recommendations
Netflix analyst commentary  »

Stifel keeps Buy rating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

OLN

Olin

$18.25

-0.015 (-0.08%)

, WLK

Westlake Chemical

$62.28

-0.24 (-0.38%)

07:17
10/17/19
10/17
07:17
10/17/19
07:17
Downgrade
Olin, Westlake Chemical rating change  »

JPMorgan downgrades Olin…

OLN

Olin

$18.25

-0.015 (-0.08%)

WLK

Westlake Chemical

$62.28

-0.24 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 05

    Nov

NURO

NeuroMetrix

$0.32

-0.0249 (-7.21%)

07:15
10/17/19
10/17
07:15
10/17/19
07:15
Earnings
NeuroMetrix reports Q3 revenue $2.1M, one estimate $3.93M »

"A new commercial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 12

    Nov

NFLX

Netflix

$286.83

2.59 (0.91%)

07:13
10/17/19
10/17
07:13
10/17/19
07:13
Recommendations
Netflix analyst commentary  »

Netflix's Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

CMA

Comerica

$65.50

-1.505 (-2.25%)

07:13
10/17/19
10/17
07:13
10/17/19
07:13
Downgrade
Comerica rating change  »

JPMorgan downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCBI

Texas Capital

$54.33

-0.15 (-0.28%)

07:12
10/17/19
10/17
07:12
10/17/19
07:12
Recommendations
Texas Capital analyst commentary  »

Texas Capital price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PM

Philip Morris

$79.12

0.8 (1.02%)

07:11
10/17/19
10/17
07:11
10/17/19
07:11
Hot Stocks
Philip Morris backs FY19 currency-neutral net revenue growth of at least 6% »

Lowers FY19 capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

GOLD

Barrick Gold

$16.95

0.3 (1.80%)

07:11
10/17/19
10/17
07:11
10/17/19
07:11
Hot Stocks
Barrick Gold sees FY production towards upper end of 5.1M-5.6M ounce guidance »

Barrick Gold Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

PFE

Pfizer

$36.34

-0.17 (-0.47%)

07:10
10/17/19
10/17
07:10
10/17/19
07:10
Initiation
Pfizer initiated  »

Pfizer reinstated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

MAIN

Main Street

$42.08

0.155 (0.37%)

07:08
10/17/19
10/17
07:08
10/17/19
07:08
Earnings
Main Street declares semi-annual supplemental cash dividend of 24c in December »

Main Street declared its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

POOL

Pool Corp.

$200.56

-4.63 (-2.26%)

07:08
10/17/19
10/17
07:08
10/17/19
07:08
Earnings
Pool Corp. raises FY19 EPS view $6.20-$6.40 from $6.09-$6.34 

Consensus $6.22.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 13

    Nov

PM

Philip Morris

$79.12

0.8 (1.02%)

07:08
10/17/19
10/17
07:08
10/17/19
07:08
Hot Stocks
Philip Morris revises FY19 shipment volume assumption to "down 1% - down 1.5" »

Prior guidance was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

AZN

AstraZeneca

$43.80

-0.41 (-0.93%)

07:07
10/17/19
10/17
07:07
10/17/19
07:07
Hot Stocks
AstraZeneca says trastuzumab deruxtecan granted FDA Priority Review »

AstraZeneca and Daiichi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

POOL

Pool Corp.

$200.56

-4.63 (-2.26%)

07:07
10/17/19
10/17
07:07
10/17/19
07:07
Earnings
Pool Corp. reports Q3 EPS ex-items $1.84, consensus $1.78 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 13

    Nov

TXMD

TherapeuticsMD

$3.70

-0.22 (-5.61%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Initiation
TherapeuticsMD initiated  »

TherapeuticsMD initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PM

Philip Morris

$79.12

0.8 (1.02%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Earnings
Philip Morris lowers FY19 EPS view to 'at least $4.73' from 'at least $4.94' »

Consensus $5.21. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

NFLX

Netflix

$286.83

2.59 (0.91%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Recommendations
Netflix analyst commentary  »

KeyBanc lowers estimates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

NBRV

Nabriva Therapeutics

$2.01

0.08 (4.15%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Conference/Events
Nabriva Therapeutics management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

BBIO

BridgeBio

$17.92

-0.6 (-3.24%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Hot Stocks
BridgeBio reports preclinical data on infigratinib in treating achondroplasia »

BridgeBio Pharma and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.